Upstream Bio (UPB) Current Assets (2023 - 2025)
Historic Current Assets for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $389.0 million.
- Upstream Bio's Current Assets rose 7116.73% to $389.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.0 million, marking a year-over-year increase of 7116.73%. This contributed to the annual value of $479.2 million for FY2024, which is 30955.25% up from last year.
- Per Upstream Bio's latest filing, its Current Assets stood at $389.0 million for Q3 2025, which was up 7116.73% from $418.3 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Current Assets ranged from a high of $479.2 million in Q4 2024 and a low of $117.0 million during Q4 2023
- Moreover, its 3-year median value for Current Assets was $403.6 million (2025), whereas its average is $347.4 million.
- Its Current Assets has fluctuated over the past 5 years, first soared by 30955.25% in 2024, then soared by 7116.73% in 2025.
- Quarter analysis of 3 years shows Upstream Bio's Current Assets stood at $117.0 million in 2023, then surged by 309.55% to $479.2 million in 2024, then fell by 18.81% to $389.0 million in 2025.
- Its Current Assets was $389.0 million in Q3 2025, compared to $418.3 million in Q2 2025 and $453.8 million in Q1 2025.